| Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
| 2011 | A novel testosterone catabolic pathway in bacteria. | Leu, Y. L.; Wang, P. H.; Shiao, M. S.; Ismail, W.; Chiang, Y. R. | JOURNAL OF BACTERIOLOGY 193, 4447-4455 | | | |
| 2002 | Anti-tumour activity and toxicity of the new prodrug 9-aminocamptothecin glucuronide (9ACG) in mice | Prijovich, Z. M.; Chen, B. M.; Leu, Y. L.; Chern, J. W.; Roffler, S. R. | British Journal of Cancer 86, 1634-1638 | | | |
| 1999 | Design and synthesis of water-soluble glucuronide derivatives of camptothecin for cancer prodrug monotherapy and antibody-directed enzyme prodrug therapy (ADEPT) | Leu, Y. L.; Roffler, S. R.; Chern, J. W. | J Med Chem 42, 3623-3628 | | | |
| 2007 | Effect of pH and human serum albumin on the cytotoxicity of a glucuronide prodrug of 9-aminocamptothecin | Prijovich, Z. M.; Leu, Y. L.; Roffler, S. R. | Cancer Chemother Pharmacol 60, 7-17 | | | |
| 2007 | Membrane-localized activation of glucuronide prodrugs by beta-glucuronidase enzymes | Chen, K. C.; Cheng, T. L.; Leu, Y. L.; Prijovich, Z. M.; Chuang, C. H.; Chen, B. M.; Roffler, S. R. | Cancer Gene Ther 14(2), 187-200 | | | |
| 2003 | Proactive antitumor compounds | Roffler, S. R.; Chern, J. W.; Leu, Y. L. | European Patent EP0990661 | | | |
| 2000 | Proactive antitumor compounds | Roffler, S. R.; Chern, J. W.; Leu, Y. L. | US Patent #6,043,367 | | | |
| 2003 | Stability of the new prodrug 9-aminocamptothecin glucuronide (9ACG) in the presence of human serum albumin | Prijovich, Z. M.; Leu, Y. L.; Roffler, S. R. | Biochem Pharmacol 66, 1181-1187 | | | |
| 1997 | Synthesis and cytotoxic evaluation of substituted sulfonyl-N-hydroxyguanidine derivatives as potential antitumor agents | Chern, J. W.; Leu, Y. L.; Wang, S. S.; Jou, R.; Lee, C. F.; Tsou, P. C.; Hsu, S. C.; Liaw, Y. C. ; Lin, H. M. | J Med Chem 40, 2276-2286 | | | |
